Skip to content

Pre-biopsy With Dynamic Acquisitions

Determination of Sensitivity of a Dual-Headed Small Field of View Gamma Camera for the Detection of Small Breast Lesions

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00943644
Enrollment
185
Registered
2009-07-22
Start date
2005-08-31
Completion date
2010-09-30
Last updated
2011-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

MBI, Breast, Breast Cancer

Brief summary

This study is being done to test the ability of an investigational mammography camera to find small tumors in patients' breasts.

Detailed description

If you agree to take part in this study, you will be asked to remove your clothes from the waist up and put on a gown. A female technologist will give you an injection of Tc-99m sestamibi in a vein in your arm. This is a drug routinely used for breast imaging. About 10 minutes after your injection, you will be asked to sit in a chair for about 40 minutes. The technologist will position your breast between two small cameras. The cameras will apply a very light compression to your breast to make sure there is no movement during the picture. We will take two pictures of each breast. Each picture takes 10 minutes. You will also be asked to fill out a short questionnaire. If you are found to have additional breast lesions, your doctor and radiologist will be notified so that additional imaging or biopsies can be performed.

Interventions

To determine the sensitivity of MBI

DEVICECZT semiconductor detectors

Dual headed CZT semiconductor detectors

Sponsors

Susan G. Komen Breast Cancer Foundation
CollaboratorOTHER
Mayo Clinic
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Have a lesion on Mammogram, Ultrasound or MRI that measured \< 2 cm and considered suspicious or suggestive of malignancy * Scheduled for biopsy of lesion * \> 18 years of age * Negative pregnancy test, postmenopausal, or surgically sterilized

Exclusion criteria

* Prior needle biopsy

Design outcomes

Primary

MeasureTime frame
To determine the sensitivity of the dual-head system relative to single-head for detection of sub 10 mm breast lesions, and to determine the number of images that need to be acquired.2 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026